ALNY Competitors & Alternatives
Compare Alnylam Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ALNY
Main Stock$219.00
Tradestie Score
42
Market Cap
$60.38B
P/E Ratio
38.5
Revenue Growth
0.7%
Analyst Upside
+76.4%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$844.50
|
$46.96B | 31.7 | 57 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$323.01
|
$36.81B | 71.0 | 53 | Compare |
|
INSM
Insmed, Inc.
|
$98.75
|
$31.13B | - | 46 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$91.35
|
$24.57B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$29.02
|
$19.56B | 21.9 | 54 | Compare |
|
INCY
Incyte Genomics Inc
|
$120.60
|
$16.93B | 15.1 | 55 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.48
|
$15.70B | 30.1 | 58 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$13.76
|
$15.22B | - | 51 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$166.06
|
$13.59B | 24.4 | 58 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$244.59
|
$12.36B | 28.0 | 55 | Compare |
More ALNY Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry